Preparation method of albizia flower fermentation liquor and application of albizia flower fermentation liquor in cosmetics

Abstract

The invention discloses albizia julibrissin flower fermentation liquor, which is characterized in that the albizia julibrissin flower fermentation liquor is obtained by fermenting albizia julibrissin flowers by adopting lactobacillus plantarum (lactobacillus plantarum). The fermentation method is simple and rapid, and the obtained albizia flower fermentation liquor has skin care effects of whitening, moisturizing, controlling oil, resisting aging and the like.

Description

Technical Field

[0001] The invention relates to the technical field of medicines, and in particular to a method for preparing a julibrissin flower fermented liquid and application of the fermented liquid in cosmetics. Background Art

[0002] The flower of Albizia Julibrissin durazz. is the dried inflorescence or bud of the leguminous plant Albizia Julibrissin durazz. It is native to Hebei, Henan, Shaanxi, Zhejiang, Jiangsu, Shandong, Anhui, Hubei and other places. It is a plant widely used in traditional herbal medicine. The "Shennong's Herbal Classic" first recorded the flower of Albizia Julibrissin: "It can calm the five internal organs, benefit the mind, and make people happy and worry-free."

[0003] my country has abundant resources of Albizzia julibrissin, and its active ingredients are mainly used in traditional Chinese medicine pharmacology, such as the treatment of depression, insomnia, anxiety, palpitations, etc. In addition, modern research on the active ingredients of Albizzia julibrissin focuses on the efficacy research in the medical field, such as anti-oxidation, antibacterial, and immune regulation, while there are fewer studies and applications on the whitening, moisturizing, and anti-aging effects related to the cosmetics field.

[0004] As consumers pay more attention to natural and green skin care ingredients, Albizzia julibrissin extract, as a natural ingredient, has the potential to compete in the natural skin care market. The chemical components in Albizzia julibrissin are mainly flavonoids, followed by polysaccharides and volatile substances. The use of appropriate extraction processes can effectively extract the active ingredients in Albizzia julibrissin and release their biological activity.

[0005] At present, the extraction process of the active ingredients of Albizzia julibrissin usually uses solvents such as ethanol, acetone, and water for extraction, or combines auxiliary technologies such as ultrasound and microwave. Existing patents also focus on using the above methods to extract certain single ingredients in Albizzia julibrissin, such as flavonoids and polysaccharides. However, the use of organic solvents may pose safety risks, environmental pollution, and loss of active ingredients. This extraction method that focuses on a single target ingredient also leads to the failure to fully explore other potential active ingredients.

[0006] As an environmentally friendly and efficient biotransformation method, fermentation technology not only avoids the problems caused by the use of organic solvents, but also effectively retains and transforms a variety of active ingredients in the raw materials compared to traditional organic solvent extraction methods. Its broad application prospects make it worthy of in-depth research and development. However, there are currently no reports on the extraction process of Albizzia julibrissin using fermentation technology and its efficacy development. Summary of the invention

[0007] Based on this, the present invention provides a julibrissin flower fermentation liquid, which is obtained by fermenting the julibrissin flower with Lactobacillus plantarum.

[0008] According to another aspect of the present invention, there is provided a method for preparing the above fermentation broth, the method comprising the following steps:

[0009] (1) Weighing an appropriate amount of Albizzia julibrissin, crushing, and sieving to obtain Albizzia julibrissin powder;

[0010] (2) adding a culture medium into a container, adding the Albizia Julibrissin powder and seed liquid, and fermenting to obtain a crude fermentation liquid; and

[0011] (3) inactivating and purifying the crude fermentation liquid to obtain the Albizia Julibrissin fermentation liquid.

[0012] Furthermore, the sieve is a 10-mesh sieve.

[0013] Furthermore, the mass ratio of the Albizia Julibrissin powder to the culture medium is 0.005-0.1, such as 0.01-0.08, such as 0.03-0.08.

[0014] Furthermore, the volume ratio of the seed solution to the culture medium is 0.03 to 0.2, such as 0.04 to 0.15, such as about 0.06 to 0.1.

[0015] Furthermore, the culture medium is a liquid culture medium.

[0016] Furthermore, the container is a fermentation tank.

[0017] Further, the fermentation temperature is 20-45°C, such as 20-40°C, such as 25-40°C.

[0018] Furthermore, the fermentation pH is 2-7, such as 3-7, such as 4-7.

[0019] Furthermore, the fermentation rotation speed is 10 to 1000 r / min, such as 50 to 800 r / min, such as 100 to 600 r / min.

[0020] Furthermore, the fermentation time is 12 to 72 hours, such as 18 to 48 hours.

[0021] Furthermore, the inactivation temperature is 115-121°C.

[0022] Furthermore, the inactivation time is 10 to 30 minutes, for example, about 20 minutes.

[0023] Further, the purification includes filtering and sterilizing the crude fermentation broth.

[0024] Furthermore, the seed solution is obtained by culturing the Lactobacillus plantarum in a seed culture medium.

[0025] Furthermore, the Lactobacillus plantarum is activated Lactobacillus plantarum.

[0026] Furthermore, the seed culture medium is a liquid seed culture medium.

[0027] Furthermore, the Lactobacillus plantarum is isolated from fermentation slurry.

[0028] Furthermore, the plant lactobacillus (Lactiplantibacillus plantarum) is deposited in the General Microbiology Center of China Microorganism Culture Collection Administration, with the deposit number being CGMCC No.28500 and the deposit date being September 20, 2023.

[0029] According to another aspect of the present invention, there is provided a use of the fermentation broth in preparing cosmetics having whitening, moisturizing, oil-controlling and / or anti-aging effects.

[0030] According to another aspect of the present invention, there is provided a use of a composition comprising the fermentation broth in preparing cosmetics having whitening, moisturizing, oil-controlling and / or anti-aging effects.

[0031] Furthermore, the whitening is to inhibit cellular melanin synthesis.

[0032] Furthermore, the moisturizing promotes the synthesis of aquaporin 3.

[0033] Furthermore, the oil control is to inhibit the formation of lipid droplets.

[0034] Furthermore, the anti-aging effect is achieved through one or more of the following ways: protecting type I collagen, inhibiting the production of MMP-1 and inhibiting the production of MMP-9.

[0035] Furthermore, the composition further comprises one or more auxiliary materials.

[0036] Furthermore, the auxiliary material is selected from one or more of the following: thickener, surfactant, co-surfactant, skin conditioner, preservative, flavor, lubricant, disintegrant, wetting agent, binder and filler.

[0037] Furthermore, the composition further comprises one or more whitening substances.

[0038] Beneficial effects of the present invention:

[0039] The invention utilizes Lactiplantibacillus plantarum separated from fermented slurry to ferment the julibrissin flower. The method is simple and rapid. The obtained julibrissin flower fermented liquid has skin care effects on skin whitening, moisturizing, oil control and anti-aging, and is suitable for popularization and application. BRIEF DESCRIPTION OF THE DRAWINGS

[0040] In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the drawings required for use in the description of the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without exceeding the scope of protection required by the present invention.

[0041] Figure 1 The figure is a schematic diagram of the results of the fermented liquor of Albizia Julibrissin inhibiting the synthesis of melanin in A375 cells, wherein BC is a blank control (A375 cells), PC is a positive control (0.5% w / w 377), and compared with BC, * represents P < 0.05, and ** represents P < 0.01.

[0042] Figure 2 The figure is a schematic diagram showing the results of the fermented liquor of Albizia Julibrissin promoting the synthesis of aquaporin 3 (AQP3). BC: blank control (HaCaT cells), PC: positive control (0.5% w / w CaCl2), compared with BC, * represents P < 0.05, ** represents P < 0.01.

[0043] Figure 3 The figure is a schematic diagram of the results of the fermented liquid of Albizzia julibrissin in the present invention inhibiting the formation of lipid droplets under the stimulation of 5α-DHT. BC: blank control (SZ95 cells), NC: negative control (1 μM 5α-DHT), PC: positive control (3 μg / mL isotretinoin); compared with BC, # represents P < 0.05, ## represents P < 0.01; compared with NC, * represents P < 0.05, ** represents P < 0.01.

[0044] Figure 4 The figure is a schematic diagram of the results of the Albizia Julibrissin fermented liquid protecting type I collagen under UVA stimulation. BC: blank control (human skin fibroblasts), NC: negative control (9 J / cm 2 UVA stimulation), PC: positive control (100 μg / mL VC + 7 μg / mL VE); compared with BC, # represents P < 0.05, ## represents P < 0.01; compared with NC, * represents P < 0.05, ** represents P < 0.01.

[0045] Figure 5 The diagram is a result of the fermented liquid of Albizzia julibrissin inhibiting the synthesis of MMP-1 under UVA stimulation. BC: blank control (human skin fibroblasts), NC: negative control (UVA stimulation of 9 J / cm2), PC: positive control (100 μg / mL VC+7 μg / mL VE); compared with BC, # represents P < 0.05, ## represents P < 0.01; compared with NC, * represents P < 0.05, ** represents P < 0.01.

[0046] Figure 6 The diagram is a result of the fermented liquid of Albizia Julibrissin in the present invention inhibiting the synthesis of MMP-9 under UVA stimulation. BC: blank control (human skin fibroblasts), NC: negative control (UVA stimulation of 9 J / cm2), PC: positive control (100 μg / mL VC+7 μg / mL VE); compared with BC, # represents P < 0.05, ## represents P < 0.01; compared with NC, * represents P < 0.05, ** represents P < 0.01. DETAILED DESCRIPTION

[0047] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative work are within the scope of protection of the present invention.

[0048] Unless otherwise indicated, all technical and scientific terms and abbreviations used herein have the meanings commonly understood by those of ordinary skill in the field of the invention or the field in which the terms are used. Although any methods, conditions, substances or materials similar to or equivalent to those disclosed herein may be used in the practice of the present invention, preferred methods, conditions, substances or materials are described herein.

[0049] The present invention is intended to encompass all alternatives, variations and equivalents that may be included in the present invention as defined by the claims. Those skilled in the art will recognize many methods and materials similar or equivalent to those described herein that can be used in the practice of the present invention. The present invention is in no way limited to the methods and materials described.

[0050] As used in the specification and the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise.

[0051] In the present invention, the term "comprising" is synonymous with "including". As used herein, the terms "comprising", "including", "having", "containing" or any other variation thereof are intended to cover a non-exclusive inclusion. For example, a composition, process, method, article, or apparatus comprising the listed elements is not necessarily limited to only those elements, but may include other elements not expressly listed or inherent to such composition, process, method, article, or apparatus.

[0052] As described in the background technology section, there is no related report in the prior art that the Albizzia julibrissin fermented liquid obtained by fermenting Albizzia julibrissin with Lactiplantibacillus plantarum has skin care effects such as whitening, moisturizing, oil control and anti-aging. In order to solve the above problems, the present invention provides a Albizzia julibrissin fermented liquid, which is obtained by fermenting Albizzia julibrissin with Lactiplantibacillus plantarum.

[0053] According to another aspect of the present invention, there is provided a method for preparing the above fermentation broth, the method comprising the following steps:

[0054] (1) Weighing an appropriate amount of Albizzia julibrissin, crushing, and sieving to obtain Albizzia julibrissin powder;

[0055] (2) adding a culture medium into a container, adding the Albizia Julibrissin powder and seed liquid, and fermenting to obtain a crude fermentation liquid; and

[0056] (3) inactivating and purifying the crude fermentation liquid to obtain the Albizia Julibrissin fermentation liquid.

[0057] In a preferred embodiment, the sieve is a 10 mesh sieve.

[0058] In the present invention, when a ratio, temperature, pH, rotation speed, time, or other value or parameter is expressed as a range, a preferred range, or a range defined by a series of upper preferred values ​​and lower preferred values, it should be understood that all ranges formed by any pairing of any range upper limit or preferred value and any range lower limit or preferred value are specifically disclosed, regardless of whether the range is disclosed separately. For example, when the range "0.01-0.08" is disclosed, the described range should be interpreted as including the range "0.01-0.08", "0.01-0.06", "0.01-0.04", "0.01-0.02", "0.02-0.08", "0.02-0.06", "0.02-0.04", "0.04-0.08", "0.04-0.06", "0.06-0.08" and the like. When a numerical range is described herein, unless otherwise stated, the range is intended to include its end values ​​and all integers and fractions within the range.

[0059] The present invention utilizes the metabolic activity of microorganisms to convert natural ingredients into more stable and more active compounds. Compared with traditional extraction methods, the fermentation process can not only improve the purity and stability of active ingredients, but also reduce dependence on raw materials and reduce the impact on the environment. Therefore, it is of great significance in the production of cosmetics.

[0060] In a preferred embodiment, the mass ratio of the Albizia Julibrissin powder to the culture medium is 0.005-0.1, such as 0.01-0.08, such as 0.03-0.08.

[0061] In a preferred embodiment, the volume ratio of the seed solution to the culture medium is 0.03-0.2, such as 0.04-0.15, such as about 0.06-0.1.

[0062] In a preferred embodiment, the culture medium is a liquid culture medium.

[0063] In a preferred embodiment, the container is a fermenter.

[0064] In a preferred embodiment, the fermentation temperature is 20-45°C, such as 20-40°C, such as 25-40°C.

[0065] In a preferred embodiment, the pH of the fermentation is 2-7, such as 3-7, such as 4-7.

[0066] In a preferred embodiment, the fermentation rotation speed is 10-1000 r / min, such as 50-800 r / min, such as 100-600 r / min.

[0067] In a preferred embodiment, the fermentation time is 12 to 72 hours, such as 18 to 48 hours.

[0068] In a preferred embodiment, the inactivation temperature is 115-121°C.

[0069] In a preferred embodiment, the inactivation time is 10 to 30 minutes, such as about 20 minutes.

[0070] In a preferred embodiment, the purification comprises filtering and sterilizing the crude fermentation broth.

[0071] In a preferred embodiment, the seed liquid is obtained by culturing the Lactobacillus plantarum in a seed culture medium.

[0072] In a preferred embodiment, the Lactobacillus plantarum is activated Lactobacillus plantarum.

[0073] In a preferred embodiment, the seed culture medium is a liquid seed culture medium.

[0074] In a preferred embodiment, the Lactiplantibacillus plantarum is isolated from fermentation slurry.

[0075] In a preferred embodiment, the Lactobacillus plantarum is deposited in the General Microbiology Center of China National Microbiological Culture Collection Administration, with a deposit number of CGMCC No. 28500 and a deposit date of September 20, 2023.

[0076] For other information about the above-mentioned strains used in the present invention, please refer to the information disclosed in application number 202410502170.3 and publication number CN118165889A.

[0077] According to another aspect of the present invention, there is provided a use of the fermentation broth in preparing cosmetics having whitening, moisturizing, oil-controlling and / or anti-aging effects.

[0078] According to another aspect of the present invention, there is provided a use of a composition comprising the fermentation broth in preparing cosmetics having whitening, moisturizing, oil-controlling and / or anti-aging effects.

[0079] In a preferred embodiment, the whitening is to inhibit cellular melanin synthesis.

[0080] In a preferred embodiment, the moisturizing is to promote the synthesis of aquaporin 3.

[0081] In a preferred embodiment, the oil control is to inhibit the formation of lipid droplets.

[0082] In a preferred embodiment, the anti-aging effect is achieved through one or more of the following ways: protecting type I collagen, inhibiting the production of MMP-1, and inhibiting the production of MMP-9.

[0083] In a preferred embodiment, the composition further comprises one or more auxiliary materials.

[0084] In a preferred embodiment, the auxiliary material is selected from one or more of the following: thickener, surfactant, co-surfactant, skin conditioner, preservative, flavor, lubricant, disintegrant, wetting agent, binder and filler.

[0085] In a preferred embodiment, the composition further comprises one or more whitening substances.

[0086] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples without specifying specific conditions are usually carried out according to conventional conditions or conditions recommended by the manufacturer.

[0087] Unless otherwise defined, all professional and scientific terms used herein have the same meanings as those familiar to those skilled in the art. In addition, any methods and materials similar or equivalent to those described herein can be applied to the methods of the present invention. The preferred implementation methods and materials described herein are for demonstration purposes only.

[0088] The above features mentioned in the present invention or the features mentioned in the embodiments can be combined in any way. All the features disclosed in this patent specification can be used in combination with any combination form, and each feature disclosed in the specification can be replaced by any alternative feature that can provide the same, equal or similar purpose. Therefore, unless otherwise specified, the disclosed features are only general examples of equal or similar features.

[0089] Example

[0090] Preparation Example

[0091] Experimental instruments and materials

[0092] Biochemical incubator (LRH-150, Shanghai Yiheng), autoclave (SYQ-DSX-280B, Shanghai Shen'an), clean bench (SW-CJ-2F, Suzhou Purification), centrifuge (Hermle, Z216M), fully automatic double water purifier (Shanghai Jinke Industry, SZ-93), anaerobic box (ANAEROPACK, Mitsubishi Gas), rotary evaporator (R-206, Shanghai Shensheng), circulating water vacuum pump (SHZ-D, Shanghai Yuhua), MRS broth culture medium (Beijing Luqiao), MRS agar culture medium (Oxoid).

[0093] The Albizia Julibrissin used in this example was purchased from Shanghai Jiangqiao Wholesale Market, a dried sample of Albizia Julibrissin produced in Hubei, and was identified as the inflorescence and flower buds of the leguminous plant Albizia Julibrissin Durazz. It was placed in a ventilated and dry place for storage. The white plum blossom used in this example was purchased from Shanghai Jiangqiao Wholesale Market, a dried sample of white plum blossom produced in Anhui, and was identified as the flower buds of the Rosaceae plant Prunus mumef.viridicalyx (Makino) TYChen. It was placed in a ventilated and dry place for storage.

[0094] Example 1

[0095] The flowers of Albizzia julibrissin were crushed by a grinder and passed through a 10-mesh screen. The crushed flowers of Albizzia julibrissin were then added at 3% of the mass fraction of the fermentation medium, and the activated Lactobacillus plantarum seed solution was added at an inoculum amount of 6% of the volume percentage of the fermentation medium. The fermentation temperature was 25°C, the pH was 4.0, the speed was 100r / min, and the fermentation time was 18h. After the fermentation was completed, the prepared fermentation liquid was inactivated and purified multiple times to obtain Albizzia julibrissin fermentation liquid A.

[0096] Example 2

[0097] The flowers of Albizzia julibrissin are crushed by a grinder and passed through a 10-mesh screen. The crushed flowers of Albizzia julibrissin are then added according to 8% of the mass fraction of the fermentation medium, and the activated Lactobacillus plantarum seed solution is added according to an inoculum amount of 10% of the volume percentage of the fermentation medium. The fermentation temperature is 40°C, the pH is 7.0, the speed is 600r / min, and the fermentation time is 48h. After the fermentation is completed, the prepared fermentation liquid is inactivated and purified multiple times to obtain Albizzia julibrissin fermentation liquid B.

[0098] Comparative Example 1

[0099] The flowers of Albizzia julibrissin were crushed by a grinder and passed through a 10-mesh screen. The crushed flowers of Albizzia julibrissin were then added according to 15% of the mass fraction of the fermentation medium, and the activated Lactobacillus plantarum seed solution was added according to an inoculum amount of 6% of the volume percentage of the fermentation medium. The fermentation temperature was 25°C, the pH was 4.0, the speed was 100r / min, and the fermentation time was 18h. After the fermentation was completed, the prepared fermentation liquid was inactivated and purified multiple times to obtain Albizzia julibrissin fermentation liquid C.

[0100] Comparative Example 2

[0101] The flowers of Albizzia julibrissin were crushed by a grinder and passed through a 10-mesh screen. The crushed flowers of Albizzia julibrissin were then added at 3% of the mass fraction of the fermentation medium, and the activated Lactobacillus plantarum seed solution was added at an inoculum amount of 2% of the volume percentage of the fermentation medium. The fermentation temperature was 25°C, the pH was 4.0, the speed was 100r / min, and the fermentation time was 18h. After the fermentation was completed, the prepared fermentation liquid was inactivated and purified multiple times to obtain Albizzia julibrissin fermentation liquid D.

[0102] Comparative Example 3

[0103] The flowers of Albizzia julibrissin were crushed by a grinder and passed through a 10-mesh screen. The crushed flowers of Albizzia julibrissin were then added at 3% of the mass fraction of the fermentation medium, and the activated Lactobacillus plantarum seed solution was added at an inoculum amount of 6% of the volume percentage of the fermentation medium. The fermentation temperature was 65°C, the pH was 4.0, the speed was 100r / min, and the fermentation time was 18h. After the fermentation was completed, the prepared fermentation liquid was inactivated and purified multiple times to obtain Albizzia julibrissin fermentation liquid E.

[0104] Comparative Example 4

[0105] The flowers of Albizzia julibrissin are crushed by a grinder and passed through a 10-mesh screen. The crushed flowers of Albizzia julibrissin are then added at 3% of the mass fraction of the fermentation medium, and the activated Lactobacillus plantarum seed solution is added at an inoculum amount of 6% of the volume percentage of the fermentation medium. The fermentation temperature is 25°C, the pH is 9.0, the speed is 100r / min, and the fermentation time is 18h. After the fermentation is completed, the prepared fermentation liquid is inactivated and purified multiple times to obtain Albizzia julibrissin fermentation liquid F.

[0106] Comparative Example 5

[0107] The flowers of Albizzia julibrissin are crushed by a grinder and passed through a 10-mesh screen. The crushed flowers of Albizzia julibrissin are then added at 3% of the mass fraction of the fermentation medium, and the activated Lactobacillus plantarum seed solution is added at an inoculum amount of 6% of the volume percentage of the fermentation medium. The fermentation temperature is 25°C, the pH is 4.0, the speed is 1200r / min, and the fermentation time is 18h. After the fermentation is completed, the prepared fermentation liquid is inactivated and purified multiple times to obtain Albizzia julibrissin fermentation liquid G.

[0108] Comparative Example 6

[0109] The flowers of Albizzia julibrissin were crushed by a grinder and passed through a 10-mesh screen. The crushed flowers of Albizzia julibrissin were then added at 3% of the mass fraction of the fermentation medium, and the activated Lactobacillus plantarum seed solution was added at an inoculum amount of 6% of the volume percentage of the fermentation medium. The fermentation temperature was 25°C, the pH was 4.0, the speed was 100r / min, and the fermentation time was 96h. After the fermentation was completed, the prepared fermentation liquid was inactivated and purified multiple times to obtain the Albizzia julibrissin fermentation liquid H.

[0110] Comparative Example 7

[0111] The flowers of Albizzia julibrissin are crushed by a grinder and passed through a 10-mesh screen. The crushed flowers of Albizzia julibrissin are then added to the fermentation medium at a mass fraction of 3%, and the sterile seed liquid culture medium system is added at an inoculation amount of 6% of the volume percentage of the fermentation medium. The fermentation temperature is 25°C, the pH is 4.0, the speed is 100r / min, and the fermentation time is 18h. After the fermentation is completed, the prepared fermentation liquid is inactivated and purified multiple times to obtain Albizzia julibrissin fermentation liquid I.

[0112] Comparative Example 8

[0113] The white plum blossoms were crushed by a grinder and passed through a 10-mesh screen. The crushed white plum blossoms were then added to the fermentation medium at a mass fraction of 3%, and the activated lactobacillus seed solution was added at an inoculum amount of 6% of the volume percentage of the fermentation medium. The fermentation temperature was 25°C, the pH was 4.0, the speed was 100r / min, and the fermentation time was 18h. After the fermentation was completed, the prepared fermentation liquid was inactivated and purified multiple times to obtain the white plum blossom fermentation liquid J.

[0114] Efficacy Example

[0115] Efficacy Example 1: Determination of the inhibition rate of melanin synthesis in A375 cells (whitening)

[0116] 1.1 Experimental instruments and reagents

[0117] Biological safety cabinet (Sujing Antai, BSC-1004IIA2), inverted fluorescence microscope (Leica, DMi8), vortex oscillator (Shanghai Hanno, XH-D), CO2 incubator (Thermo Scientific), microplate reader (Thermo Scientific), 24-well plate (Coming Incorporated), 96-well plate (Coming Incorporated), 6 cm culture dish (Coming Incorporated), DMSO (Sigma), NaOH (Sinopharm), cell lysis buffer (Gibco), DMEM medium (Gibco), double antibody Pen Strep (Gibco), fetal bovine serum (Gibco), 0.05% Trypsin-EDTA (Gibco), PBS (Vivacell), MTT (Sigma).

[0118] 1.2 Experimental Methods

[0119] Cell seeding: 1×10 5 A375 cells (Stem Cell Bank, Chinese Academy of Sciences) were seeded into 24-well plates at a seeding density of 10 cells / well and incubated overnight in an incubator (37° C., 5% CO 2 ).

[0120] Liquid preparation: Prepare the working solution of the test substance according to the experimental design (Table 1). Take 50 mg of 377, nonapeptide-1, and glabridin powder, respectively, and add 10 mL of DMEM medium (containing 10% fetal bovine serum) to obtain a cell culture solution with a concentration of 0.5% (w / w) of 377, nonapeptide-1, and glabridin; take 50 μL of Albizzia julibrissin fermentation liquid AI and white plum blossom fermentation liquid J, respectively, and add 10 mL of DMEM medium (containing 10% fetal bovine serum) to obtain a cell culture solution with a concentration of 0.5% (w / w) of Albizzia julibrissin fermentation liquid AI and white plum blossom fermentation liquid J; take 100 μL of Albizzia julibrissin fermentation liquid AI and white plum blossom fermentation liquid J, respectively, and add 10 mL of DMEM medium (containing 10% fetal bovine serum) to obtain a cell culture solution with a concentration of 1% (w / w) of Albizzia julibrissin fermentation liquid AI and white plum blossom fermentation liquid J;

[0121] Table 1 Pharmacodynamics Example 1 Experimental Design

[0122]

[0123] Administration: After 24 hours of culture, according to the experimental design in Table 1, the groups were administered. 1 mL of cell culture medium was added to each well of the blank control group; 1 mL of culture medium containing 0.5% (w / w) 377 was added to each well of the positive control group; 1 mL of culture medium containing the test substance at the corresponding concentration was added to each well of the sample group; after the administration, the 24-well plate was placed in an incubator (37°C, 5% CO2) and cultured for 24 hours.

[0124] Detection: 72 hours after the third liquid change, measure the melanin content of the cells. Wash the cells twice with 1×PBS, remove the PBS, add 200μL 0.25% trypsin to each well to digest the cells, and digest them in a CO2 incubator for 5 minutes. Add 2mL PBS twice to blow the cells, collect the cells into a centrifuge tube, and centrifuge at 4000rpm for 5 minutes. Try to suck out the residual PBS in the centrifuge tube, add 200μL of melanin extract to each tube, shake evenly, and heat in an 80℃ water bath for 1h. After cooling, centrifuge the droplets on the tube wall moderately, blow evenly, aspirate 150μL of solution in each centrifuge tube, transfer to a 96-well plate, and use an enzyme reader to detect the absorbance (OD) of each well at 405nm.

[0125] The relative inhibition rate of melanin was calculated.

[0126] Melanin inhibition rate (%) = [1-(OD of drug well-OD of blank well) / (OD of cell control well-OD of blank well)] × 100

[0127] 1.3 Experimental Results

[0128] like Figure 1As shown, compared with the BC group, the 0.5% (w / w) concentration of 377 in the PC group significantly increased the melanin inhibition rate, indicating that the experimental system is effective. Compared with the BC group, the common whitening monomer raw materials nonapeptide-1 and glabridin in the test group significantly improved the melanin inhibition rate at a concentration of 0.5%; compared with the BC group, the Albizzia julibrissin fermented liquid A and B described in Examples 1 and 2 improved the melanin inhibition rate at a concentration of 0.5%, and significantly improved the melanin inhibition rate at a concentration of 1%, which was close to the inhibition rate of nonapeptide-1 and glabridin at a concentration of 0.5%, indicating that the Albizzia julibrissin fermented liquid A and Albizzia julibrissin fermented liquid B have the ability to inhibit melanocytes from synthesizing melanin and have whitening effects; while in Comparative Examples 1-8, the Albizzia julibrissin fermented liquid CI and white plum blossom fermented liquid J had no statistically significant differences between the groups at concentrations of 0.5% and 1% compared with the BC group (P>0.05), and therefore did not show the ability to inhibit melanocytes from synthesizing melanin; it proves that only within the scope of the preparation method described in the claims, the Albizzia julibrissin fermented liquid prepared has whitening effects.

[0129] Efficacy Example 2: Promoting the synthesis of aquaporin 3 (AQP3) (moisturizing) --- Determination of the content of aquaporin 3

[0130] 2.1 Experimental instruments and reagents

[0131] Biosafety cabinet (Sujing Antai, BSC-1004IIA2), inverted fluorescence microscope (Leica, DMi8), micro-oscillator (Qilin Bell, TS-92). High-glucose DMEM culture medium (Gibco), fetal bovine serum (Gibco), PBS (Gibco), MTT (Sigma), trypsin (Gibco).

[0132] 2.2 Experimental Methods

[0133] Cell seeding: 1×10 5 Keratinocytes HaCaT (Stem Cell Bank, Chinese Academy of Sciences) were seeded into 24-well plates at a seeding density of 10 cells / well and incubated overnight in an incubator (37° C., 5% CO 2 ).

[0134] Solution preparation: Referring to the solution preparation method of Example 1, prepare the working solution of the test substance according to the experimental design (Table 2).

[0135] Table 2 Pharmacodynamics Example 2 Experimental Design

[0136]

[0137] Drug administration: According to the experimental design in Table 2, when the cell plating rate in the 24-well plate reaches 40% to 60%, group drug administration is carried out, the dosage per well is 1.0 mL, and each group has 3 replicate wells. The culture is continued in the incubator (37°C, 5% CO2) for 24 hours.

[0138] Detection: Collect the sample, discard the supernatant, and rinse the cells 3 times with PBS. Perform the routine immunofluorescence staining process. Add 100% methanol to fix the cells, rinse with PBS 3 times, and add 1mL 1% BSA to each well for 1h. Discard the blocking solution, add 5μg / mL primary antibody to each well, and place in a 4℃ refrigerator overnight. Discard the primary antibody and rinse with PBS 3 times. Add secondary antibody to each well and act for 2h. Discard the secondary antibody and rinse with PBS 3 times. Add 1.43μM DAPI to each well for nuclear staining, act for 1h, discard DAPI, rinse with PBS 3 times, and then take pictures using a fluorescence microscope.

[0139] Result analysis: Image Pro Plus software was used to quantitatively analyze the fluorescence intensity of AQP3.

[0140] 2.3 Experimental Results

[0141] like Figure 2 As shown, compared with the BC group, the 0.5% (w / w) concentration of CaCl2 in the PC group significantly increased the fluorescence intensity (IOD) of the AQP3 protein, indicating that the experimental system is effective. Compared with the BC group, the Albizzia Julibrissin fermented liquid A and B described in Example 1 and Example 2 significantly increased the IOD at a concentration of 0.5% and 1%, indicating that the Albizzia Julibrissin fermented liquid A and B have the ability to promote the synthesis of aquaporin 3 (AQP3) and have a moisturizing effect; while in Comparative Examples 1-8, the Albizzia Julibrissin fermented liquid CI and the white plum blossom fermented liquid J at a concentration of 0.5% and 1% compared with the BC group, the differences between the groups were not statistically significant (P>0.05), so they did not show the ability to promote the synthesis of AQP3; it proves that only within the scope of the preparation method described in the claims, the Albizzia Julibrissin fermented liquid has a moisturizing effect.

[0142] Efficacy Example 3: Inhibition of lipid droplet formation (5α-DHT) (oil control) --- Determination of lipid droplet content in SZ95 cells stimulated by 5α-DHT

[0143] 3.1 Experimental instruments and reagents

[0144] Biological safety cabinet (Sujing Antai, BSC-1004IIA2), CO2 incubator (Thermo Scientific), microvibrator (Qilin Bell, TS-92), ultra-low temperature refrigerator (-80℃, Thermo), low-speed centrifuge (bioridge), precision balance (Mettler, ME204), inverted microscope (Leica, DMi8), microplate reader (Thermo Scientific), PBS (Viva cell), 5α-DHT (Selleck, USA), isotretinoin (Shanghai Yuanye), and Nile red dye (Shanghai Yuanye).

[0145] 3.2 Experimental Methods

[0146] Cell seeding: 1×10 5 SZ95 cells (Stem Cell Bank, Chinese Academy of Sciences) were seeded into 24-well plates at a seeding density of 10 cells / well and incubated overnight in an incubator (37° C., 5% CO 2 ).

[0147] Solution preparation: Referring to the solution preparation method of Example 1, prepare the working solution of the test substance according to the experimental design (Table 3).

[0148] Table 3 Pharmacodynamics Example 3 Experimental Design

[0149]

[0150]

[0151] Drug administration: According to the experimental design in Table 3, when the cell plating rate in the 24-well plate reaches 40% to 60%, group drug administration is carried out, 10% 5α-DHT and activators (samples and controls) are added to each well, and 3 replicate wells are set for each group. The 24-well plate is then placed in an incubator (37°C, 5% CO2) for 24 hours.

[0152] Detection: Collect the sample, discard the supernatant, rinse the cells 3 times with PBS, and perform the conventional immunofluorescence staining process. Add 4% paraformaldehyde to fix for 30 minutes, add 0.5mg / mL Nile red dye solution to stain for about 15 minutes, rinse with sterile water / PBS 3 times to remove excess dye. After the culture is completed, observe the staining of each group of cells under an inverted fluorescence microscope and take pictures.

[0153] Result analysis: Image Pro Plus software was used to quantitatively analyze the fluorescence intensity of lipid droplets.

[0154] 3.3 Experimental Results

[0155] like Figure 3As shown, compared with the BC group, the lipid droplet fluorescence intensity of the NC group was significantly increased (P<0.01), and compared with the NC group, 3 μg / mL isotretinoin in the PC group significantly reduced the lipid droplet fluorescence intensity (P<0.01), indicating that the experimental system is effective. Compared with the NC group, the Albizzia Julibrissin fermented liquid A and B described in Example 1 and Example 2 significantly reduced the lipid droplet fluorescence intensity at a concentration of 0.5% and 1%, indicating that the Albizzia Julibrissin fermented liquid A and B have the ability to inhibit lipid droplet formation under the stimulation of 5α-DHT and have an oil control effect; while in Comparative Examples 1-8, the Albizzia Julibrissin fermented liquid CI and the white plum blossom fermented liquid J at a concentration of 0.5% and 1% compared with the NC group, the differences between the groups were not statistically significant (P>0.05), so they did not show the ability to inhibit lipid droplet formation; it proves that only within the scope of the preparation method described in the claims, the Albizzia Julibrissin fermented liquid has an oil control effect.

[0156] Efficacy Example 4: Protection of Type I Collagen (UVA) (Anti-aging) --- Determination of Type I Collagen Content in Fibroblasts Stimulated by UVA

[0157] 4.1 Experimental instruments and reagents

[0158] Biological safety cabinet (Sujing Antai, BSC-1004IIA2), CO2 incubator (Thermo Scientific), micro-oscillator (Qilin Bell, TS-92), ultra-low temperature refrigerator (-80℃, Thermo), low-speed centrifuge (bioridge), precision balance (ME204 Mettler), inverted microscope (Leica, DMi8), cell counter (Thermo), microplate reader (ThermoScientific), adjustable pipette (eppendorf), PBS (Viva cell), trypsin (Gibco), newborn calf serum (Gibco), low-glucose DMEM medium (Gibco), DMSO (Sigma), Human Collagen I alpha 1 ELISA detection kit (Thermo), type I collagen primary antibody, secondary antibody (Thermo), vitamin C (Aladdin), vitamin E (Aladdin), etc.

[0159] 4.2 Experimental Methods

[0160] Cell inoculation: Human skin fibroblasts (Stem Cell Bank, Chinese Academy of Sciences) were inoculated into 24-well plates at a density of 45% to 60% confluence 24 hours after inoculation and incubated overnight in an incubator (37° C., 5% CO 2 ).

[0161] Solution preparation: Referring to the solution preparation method of Example 1, prepare the working solution of the test substance according to the experimental design (Table 4).

[0162] Table 4 Pharmacodynamics Example 4 Experimental Design

[0163]

[0164]

[0165] Drug administration: According to the experimental design in Table 4, when the cell plating rate in the 24-well plate reaches 40% to 60%, wash with PBS, and then culture and expose to 9J / cm 2 After exposure, the treated cells were washed with PBS and then divided into groups for drug administration. The sample group was added with culture medium containing the sample, and the positive control group was added with culture medium containing the positive control. They were exposed to different test substances for 24 hours. The dosage per well was 1.0 mL, and 3 replicates were set for each group. The blank control group BC group was added with cell culture medium and treated in the same way, but covered with aluminum foil to avoid ultraviolet exposure.

[0166] Detection: Cell supernatant collection: After the incubation, collect 1 mL of cell culture supernatant in a 1.5 mL sterile centrifuge tube and store it in a -80°C ultra-low temperature refrigerator. Determine the type I collagen content according to the operating instructions of the ELISA detection kit.

[0167] Result analysis: Calculation of CollagenⅠ content: After subtracting the OD450 value of the blank well from the OD450 value of the standard and sample, the average value of the three parallel wells was calculated. Using the professional curve making software Curve Expert, the concentration of the standard was used as the ordinate and the OD450 value was used as the abscissa to draw the standard curve, and the regression equation was obtained. The OD450 value measured by the sample group was substituted into the equation to calculate the CollagenⅠ protein content of each group.

[0168] 4.3 Experimental Results

[0169] like Figure 4As shown, compared with the BC group, the type I collagen concentration of the NC group was significantly reduced (P<0.01), and compared with the NC group, 100μg / mL VC+7μg / mL VE in the PC group significantly increased the type I collagen concentration (P<0.01), indicating that the experimental system is effective. Compared with the NC group, the Albizzia Julibrissin fermented liquid A and B described in Examples 1 and 2 increased the type I collagen concentration at a concentration of 0.5%, and significantly increased the type I collagen concentration at a concentration of 1%, indicating that the Albizzia Julibrissin fermented liquid A and B have the ability to protect the type I collagen of fibroblasts under UVA stimulation, and have anti-aging effects; while in Comparative Examples 1-8, the Albizzia Julibrissin fermented liquid CI and the white plum blossom fermented liquid J were compared with the NC group at concentrations of 0.5% and 1%, and the differences between the groups were not statistically significant (P>0.05), so they did not show the ability to protect type I collagen; it proves that only within the scope of the preparation method described in the claims, the Albizzia Julibrissin fermented liquid has anti-aging effects.

[0170] Efficacy Example 5: Inhibition of MMP-1 Synthesis (UVA) (Anti-aging) --- Determination of MMP-1 Content in Fibroblasts Stimulated by UVA

[0171] 5.1 Experimental instruments and reagents

[0172] Biological safety cabinet (Sujing Antai, BSC-1004IIA2), CO2 incubator (Thermo Scientific), micro-oscillator (Qilin Bell, TS-92), ultra-low temperature refrigerator (-80℃, Thermo), low-speed centrifuge (bioridge), precision balance (ME204 Mettler), inverted microscope (Leica, DMi8), cell counter (Thermo), microplate reader (ThermoScientific), adjustable pipette (eppendorf), PBS (Viva cell), trypsin (Gibco), newborn calf serum (Gibco), low-glucose DMEM medium (Gibco), DMSO (Sigma), human MMP-1 ELISA kit (Sigma), vitamin C (Aladdin), vitamin E (Aladdin), etc.

[0173] 5.2 Experimental Methods

[0174] Cell inoculation: Human skin fibroblasts (Stem Cell Bank, Chinese Academy of Sciences) were inoculated into 24-well plates at a density of 45% to 60% confluence 24 hours after inoculation and incubated overnight in an incubator (37° C., 5% CO 2 ).

[0175] Solution preparation: Referring to the solution preparation method of Example 1, prepare the working solution of the test substance according to the experimental design (Table 5).

[0176] Table 5 Pharmacodynamics Example 5 Experimental Design

[0177]

[0178]

[0179] Drug administration: According to the experimental design in Table 5, when the cell plating rate in the 24-well plate reaches 40% to 60%, wash with PBS, and then culture and expose to 9J / cm 2 After exposure, the treated cells were washed with PBS and then divided into groups for drug administration. The sample group was added with culture medium containing the sample, and the positive control group was added with culture medium containing the positive control. They were exposed to different test substances for 24 hours. The dosage per well was 1.0 mL, and 3 replicates were set for each group. The blank control group BC group was added with cell culture medium and treated in the same way, but covered with aluminum foil to avoid ultraviolet exposure.

[0180] Detection: Cell supernatant collection: After the incubation, collect 1 mL of cell culture supernatant in a 1.5 mL sterile centrifuge tube and store it in a -80°C ultra-low temperature refrigerator. Determine the MMP-1 protein content according to the operating instructions of the ELISA detection kit.

[0181] Result analysis: The MMP-1 protein content was calculated according to the operating instructions of the ELISA detection kit.

[0182] 5.3 Experimental Results

[0183] like Figure 5 As shown, compared with the BC group, the MMP-1 concentration of the NC group was significantly increased (P<0.01), and compared with the NC group, 100μg / mL VC+7μg / mL VE in the PC group significantly reduced the MMP-1 concentration (P<0.01), indicating that the experimental system is effective. Compared with the NC group, the Albizzia Julibrissin fermented liquid A and B described in Example 1 and Example 2 reduced the MMP-1 concentration at a concentration of 0.5%, and significantly reduced the MMP-1 concentration at a concentration of 1%, indicating that the Albizzia Julibrissin fermented liquid A and B have the ability to inhibit the synthesis of MMP-1 protein by fibroblasts under UVA stimulation, and have anti-aging effects; while in Comparative Examples 1-8, the Albizzia Julibrissin fermented liquid CI and the white plum blossom fermented liquid J at 0.5% and 1% concentrations compared with the NC group, the differences between the groups were not statistically significant (P>0.05), so they did not show the ability to inhibit the synthesis of MMP-1; it proves that only within the scope of the preparation method described in the claims, the Albizzia Julibrissin fermented liquid has anti-aging effects.

[0184] Efficacy Example 6: Inhibition of MMP-9 Synthesis (UVA) (Anti-aging) --- Determination of MMP-9 Content in Fibroblasts Stimulated by UVA

[0185] 6.1 Experimental instruments and reagents

[0186] Biological safety cabinet (Sujing Antai, BSC-1004IIA2), CO2 incubator (Thermo Scientific), micro-oscillator (Qilin Bell, TS-92), ultra-low temperature refrigerator (-80℃, Thermo), low-speed centrifuge (bioridge), precision balance (ME204 Mettler), inverted microscope (Leica, DMi8), cell counter (Thermo), microplate reader (ThermoScientific), adjustable pipette (eppendorf), PBS (Viva cell), trypsin (Gibco), newborn calf serum (Gibco), low-glucose DMEM medium (Gibco), DMSO (Sigma), human MMP9 ELISA kit (Sigma), vitamin C (Aladdin), vitamin E (Aladdin), etc.

[0187] 6.2 Experimental Methods

[0188] Cell inoculation: Human skin fibroblasts (Stem Cell Bank, Chinese Academy of Sciences) were inoculated into 24-well plates at a density of 45% to 60% confluence 24 hours after inoculation and incubated overnight in an incubator (37° C., 5% CO 2 ).

[0189] Solution preparation: Referring to the solution preparation method of Example 1, prepare the working solution of the test substance according to the experimental design (Table 6).

[0190] Table 6 Pharmacodynamics Example 6 Experimental Design

[0191]

[0192]

[0193] Drug administration: According to the experimental design in Table 6, when the cell plating rate in the 24-well plate reaches 40% to 60%, wash with PBS, and then culture and expose to 9J / cm 2 After exposure, the treated cells were washed with PBS and then divided into groups for drug administration. The sample group was added with culture medium containing the sample, and the positive control group was added with culture medium containing the positive control. They were exposed to different test substances for 24 hours. The dosage per well was 1.0 mL, and 3 replicates were set for each group. The blank control group BC group was added with cell culture medium and treated in the same way, but covered with aluminum foil to avoid ultraviolet exposure.

[0194] Detection: Cell supernatant collection: After the incubation, collect 1 mL of cell culture supernatant in a 1.5 mL sterile centrifuge tube and store it in a -80°C ultra-low temperature refrigerator. Determine the MMP-9 protein content according to the operating instructions of the ELISA detection kit.

[0195] Result analysis: The MMP-9 protein content was calculated according to the operating instructions of the ELISA detection kit.

[0196] 6.3 Experimental Results

[0197] like Figure 6 As shown, compared with the BC group, the MMP-9 concentration of the NC group was significantly increased (P<0.01), and compared with the NC group, 100μg / mL VC+7μg / mL VE in the PC group significantly reduced the MMP-9 concentration (P<0.01), indicating that the experimental system is effective. Compared with the NC group, the Albizzia Julibrissin fermented liquid A and B described in Example 1 and Example 2 reduced the MMP-9 concentration at a concentration of 0.5%, and significantly reduced the MMP-9 concentration at a concentration of 1%, indicating that the Albizzia Julibrissin fermented liquid A and B have the ability to inhibit the synthesis of MMP-9 protein by fibroblasts under UVA stimulation, and have anti-aging effects; while in Comparative Examples 1-8, the Albizzia Julibrissin fermented liquid CI and the white plum blossom fermented liquid J were compared with the NC group at concentrations of 0.5% and 1%, and the differences between the groups were not statistically significant (P>0.05), so they did not show the ability to inhibit the synthesis of MMP-9; it proves that only within the scope of the preparation method described in the claims, the Albizzia Julibrissin fermented liquid has anti-aging effects.

[0198] The embodiments of the present invention are described in detail above. Specific examples are used herein to illustrate the principles and implementation methods of the present invention. The description of the above embodiments is only used to help understand the method of the present invention and its core idea. At the same time, changes or deformations made by those skilled in the art based on the ideas of the present invention, the specific implementation methods and application scope of the present invention, all belong to the scope of protection of the present invention. In summary, the content of this specification should not be understood as limiting the present invention.

Claims

1. A fermented liquid of Albizia Julibrissin, characterized in that: The fermented liquid is obtained by fermenting the flowers of Albizzia julibrissin by using Lactobacillus plantarum.

2. A method for preparing the fermentation broth according to claim 1, characterized in that: The method comprises the following steps: (1) Weighing an appropriate amount of Albizzia julibrissin, crushing, and sieving to obtain Albizzia julibrissin powder; (2) adding a culture medium into a container, adding the Albizia Julibrissin powder and seed liquid, and fermenting to obtain a crude fermentation liquid; and (3) inactivating and purifying the crude fermentation liquid to obtain the Albizia Julibrissin fermentation liquid.

3. The method according to claim 2, characterized in that The sieve is a 10-mesh sieve; Preferably, the mass ratio of the Albizia Julibrissin powder to the culture medium is 0.005 to 0.1, such as 0.01 to 0.08, such as 0.03 to 0.08; More preferably, the volume ratio of the seed solution to the culture medium is 0.03 to 0.2, such as 0.04 to 0.15, such as about 0.06 to 0.1; Also preferably, the culture medium is a liquid culture medium.

4. The method according to claim 2, characterized in that: The container is a fermentation tank; Preferably, the fermentation temperature is 20-45°C, such as 20-40°C, such as 25-40°C; Preferably, the fermentation pH is 2 to 7, such as 3 to 7, such as 4 to 7; More preferably, the fermentation speed is 10 to 1000 r / min, such as 50 to 800 r / min, such as 100 to 600 r / min; More preferably, the fermentation time is 12 to 72 hours, such as 18 to 48 hours.

5. The method according to claim 2, characterized in that: The inactivation temperature is 115-121°C; Preferably, the inactivation time is 10 to 30 minutes, for example, about 20 minutes; More preferably, the purification comprises filtering and sterilizing the crude fermentation broth.

6. The method according to claim 2, characterized in that The seed solution is obtained by culturing the Lactobacillus plantarum in a seed culture medium; Preferably, the Lactobacillus plantarum is an activated Lactobacillus plantarum; More preferably, the seed culture medium is a liquid seed culture medium; Preferably, the Lactobacillus plantarum is separated from fermentation slurry; Particularly preferably, the Lactobacillus plantarum is deposited in the General Microbiology Center of China National Microbiological Culture Collection Administration, and its deposit number is CGMCC No.28500.

7. Use of the fermentation liquid according to claim 1 in preparing cosmetics having whitening, moisturizing, oil-controlling and / or anti-aging effects.

8. Use of a composition comprising the fermentation broth according to claim 1 in preparing cosmetics having whitening, moisturizing, oil-controlling and / or anti-aging effects.

9. The use according to claim 7 or 8, characterized in that The whitening is to inhibit the synthesis of cellular melanin; Preferably, the moisturizing is to promote the synthesis of aquaporin 3; Preferably, the oil control is to inhibit the formation of lipid droplets. Preferably, the anti-aging effect is achieved through one or more of the following ways: protecting type I collagen, inhibiting the production of MMP-1 and inhibiting the production of MMP-9.

10. The use according to claim 8, characterized in that The composition further comprises one or more excipients; Preferably, the excipient is selected from one or more of the following: thickener, surfactant, co-surfactant, skin conditioner, preservative, flavor, lubricant, disintegrant, wetting agent, binder and filler; Also preferably, the composition further comprises one or more whitening substances.

Images